• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC P

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC P Back to Search Results
Model Number 7510050
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Purulent Discharge (1812); Inflammation (1932); Pain (1994)
Event Date 05/18/2021
Event Type  Injury  
Manufacturer Narrative
Medical safety assesses the reported event of infection and pus and its reported severity as not related to the device or therapy because of the following: the product is sterile.No other complaint about lot number mdh4123aaq in gch.The reported event of infection and pus and its reported severity is an inherent surgical or post-operative risk associated with dental bone graft procedures (liaw et al., 2015)." the pus formation likely caused the enlarged defect (chaffee et al., 2001).Although it is unknown whether these products caused or contributed to the reported event, we are filling this mdr for notification purpose.Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The information was received from health care provider via a manufacturing representative regarding a patient for oral maxillofacial surgery.It was reported that surgeon used infuse for bone graft on tooth 12 did the extraction and bone graft at same time.Surgeon used one x-small infuse and mineross together which is the go to combination.At two week follow up, all was fine four months later the site was full of puss and infected.Puss oozed with the touch.The updated cat scan shows the defect is much larger than it was.There was no further information received.Additional information received states that patient had past surgical history, past history, concurrent conditions, past drugs, as o prostate cancer o controlled/hbp o artificial joint  left hip, 2 elbows o distal triceps tendon repair on (b)(6) 2021 o allergies: penicillin concomitant medication: medications: 20mg qd lisinopril and baby aspirin.Initial problem: (b)(6) 2020  tooth was fractured and removed implant placed - (b)(6) 2021 implant removed on (b)(6) 2021 as implant was failing and bone grafting with infuse done on this date.On (b)(6) 2021 the patient had an implant placed from the tooth (#12) extraction, originally done in (b)(6) 2020.The patient came back to the office on (b)(6) 2021 complaining of pain and was put on an antibiotic (clindamycin).A week later (b)(6) 2021, the extraction of the implant done on (b)(6) was performed along with debridement and then bone grafting with infuse/mineross.Continued treatment with clindamycin.After 2 weeks later patient came for removal of suture on surface and it looked fine.Patient was called back in (b)(6) at that time area was painful and inflamed.On (b)(6) 2021 patient came back for follow up visit and reported pain.Was treated with cephalexin instead of clindamycin.Surgeon drained infection by hand and imaging was done with enlarged defect noted.Surgeon took out in a few pieces and let it heal before implant extraction.It might have had a large defect already in that area.Usually do both (extraction and implant) at once with tooth #12 but in this particular case they let it heal prior to grafting.There was no further information reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC P
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
david gustafson
1800 pyramid place
memphis, TN 38132
7635149628
MDR Report Key12493986
MDR Text Key272132071
Report Number1030489-2021-01174
Device Sequence Number1
Product Code NEK
UDI-Device Identifier00613994239518
UDI-Public00613994239518
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial
Report Date 09/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2021
Device Model Number7510050
Device Catalogue Number7510050
Device Lot NumberMDH4123AAQ
Was Device Available for Evaluation? No
Date Manufacturer Received08/24/2021
Date Device Manufactured11/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight77
-
-